Regeneron Pharmaceuticals Inc.
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years[...]
08/28/2023 | Press release | Distributed by Public on 08/29/2023 01:11
Please select the service you want to use:
Smartlinks | Lacroix Group SA | News | Company News | Securities Issuers | Industrial Equipment and Components Manufacturers | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Euronext Paris | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | SIGMA X MTF | Euronext Block MTF | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact